NextSeq 550Dx Instrument: FDA-regulated, CE-marked, mid-throughput sequencing platform

In this specification sheet, Illumina presents the NextSeq™ 550Dx Instrument, a mid-throughput, FDA-regulated and CE-marked NGS platform for clinical and research applications. The NextSeq™ 550Dx Instrument has dual diagnostic and research modes, enabling IVD testing, laboratory-developed tests, and clinical research on a single instrument, with up to 90 Gb of data generated in less than two days. It also notes compatibility with the DRAGEN™ Server for NextSeq 550Dx for accurate, IVDR-compliant secondary analysis and support for exome sequencing, transcriptome profiling, targeted panels, and microarray scanning.